NO924671L - Fremgangsmaate for fremstilling av poroese cellulosematriser - Google Patents

Fremgangsmaate for fremstilling av poroese cellulosematriser

Info

Publication number
NO924671L
NO924671L NO92924671A NO924671A NO924671L NO 924671 L NO924671 L NO 924671L NO 92924671 A NO92924671 A NO 92924671A NO 924671 A NO924671 A NO 924671A NO 924671 L NO924671 L NO 924671L
Authority
NO
Norway
Prior art keywords
matrices
pct
cellulose
sec
manufacture
Prior art date
Application number
NO92924671A
Other languages
English (en)
Other versions
NO304726B1 (no
NO924671D0 (no
Inventor
Bo Ragnar Ek
Kjell Gunnar Eriksson
Per Gustaf Haakon Nyqvist
Gert Anders Ragnarsson
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of NO924671L publication Critical patent/NO924671L/no
Publication of NO924671D0 publication Critical patent/NO924671D0/no
Publication of NO304726B1 publication Critical patent/NO304726B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/26—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a solid phase from a macromolecular composition or article, e.g. leaching out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2201/00—Foams characterised by the foaming process
    • C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
    • C08J2201/044—Elimination of an inorganic solid phase
    • C08J2201/0444—Salts
    • C08J2201/0446—Elimination of NaCl only
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/02—Cellulose; Modified cellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Amplifiers (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO924492A 1990-06-06 1992-12-03 FremgangsmÕte for fremstilling av por÷se cellulosematrikser NO304726B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9002017A SE9002017D0 (sv) 1990-06-06 1990-06-06 Process for manufacture of matrices
PCT/SE1991/000396 WO1991018590A1 (en) 1990-06-06 1991-06-05 Process for the manufacture of porous cellulose matrices

Publications (3)

Publication Number Publication Date
NO924671L true NO924671L (no) 1992-12-03
NO924671D0 NO924671D0 (no) 1992-12-03
NO304726B1 NO304726B1 (no) 1999-02-08

Family

ID=20379691

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924492A NO304726B1 (no) 1990-06-06 1992-12-03 FremgangsmÕte for fremstilling av por÷se cellulosematrikser

Country Status (14)

Country Link
US (1) US5607695A (no)
EP (1) EP0532611B1 (no)
JP (1) JPH05507696A (no)
AT (1) ATE136213T1 (no)
AU (1) AU644887B2 (no)
CA (1) CA2084680C (no)
DE (1) DE69118533T2 (no)
DK (1) DK0532611T3 (no)
ES (1) ES2086542T3 (no)
FI (1) FI101195B (no)
GR (1) GR3020047T3 (no)
NO (1) NO304726B1 (no)
SE (1) SE9002017D0 (no)
WO (1) WO1991018590A1 (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2702160B1 (fr) * 1993-03-02 1995-06-02 Biovecteurs As Vecteurs particulaires synthétiques et procédé de préparation.
SE9301220D0 (sv) * 1993-04-14 1993-04-14 Kabi Pharmacia Ab Manufacturing matrices
US5858409A (en) * 1996-04-17 1999-01-12 Fmc Corporation Hydrolyzed cellulose granulations for pharmaceuticals
US5855913A (en) * 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
USRE37053E1 (en) 1996-05-24 2001-02-13 Massachusetts Institute Of Technology Particles incorporating surfactants for pulmonary drug delivery
US6254854B1 (en) * 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
SE9604124D0 (sv) 1996-11-12 1996-11-12 Pharmacia & Upjohn Ab Compact member, method of manufacturing and use thereof
EP0941069A1 (en) * 1996-11-12 1999-09-15 Pharmacia & Upjohn Aktiebolag COMPACT MEMBER COMPRISING A PLURALITY OF POROUS CELLULOSE MATRICES, (PCMs), METHOD OF MANUFACTURING AND USE THEREOF
EP0955332B1 (en) * 1997-01-07 2006-07-19 Kaneka Corporation Adsorbent for body fluid purification
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
DE19745629A1 (de) * 1997-10-16 1999-04-22 Cff Cellulose Fuellstoff Fabri Verfahren zur Herstellung eines aus zerkleinerten Pflanzenfasern bestehenden Ballast- oder Füllstoffes und seine Verwendung
CN1142205C (zh) * 1997-12-14 2004-03-17 纺织品和合成材料研究协会图林根研究所 规则多孔珠状纤维素的制备方法、珠状纤维素及其用途
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
AU764469B2 (en) * 1999-01-29 2003-08-21 Disphar International B.V. Pharmaceutical compositions
US6610317B2 (en) 1999-05-27 2003-08-26 Acusphere, Inc. Porous paclitaxel matrices and methods of manufacture thereof
WO2001013891A2 (en) * 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US6858725B1 (en) 1999-11-12 2005-02-22 R.P. Scherer Technologies, Inc. Microcrystalline cellulose cushioning granules
WO2001034684A1 (en) * 1999-11-12 2001-05-17 R.P. Scherer Technologies, Inc. Microcrystalline cellulose cushioning granules
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
JP2005504715A (ja) * 2000-12-29 2005-02-17 アドバンスト インハレーション リサーチ，インコーポレイテッド 持続放出特性を有する吸入用粒子
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
US20030125236A1 (en) * 2000-12-29 2003-07-03 Advenced Inhalation Research, Inc. Particles for inhalation having rapid release properties
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
JP2004525109A (ja) 2001-02-15 2004-08-19 キング・ファーマシューティカルズ・インコーポレイティッド 安定化された甲状腺ホルモン医薬組成物、及びその製法
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
WO2003043603A1 (en) * 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Particulate compositions for improving solubility of poorly soluble agents
JP4368198B2 (ja) * 2001-11-20 2009-11-18 アルカーメス，インコーポレイテッド 肺送達用の改良された粒状組成物
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
TW200507882A (en) * 2003-07-17 2005-03-01 Kyowa Hakko Kogyo Kk Solid formulations
US7198653B2 (en) * 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
BRPI0507139A (pt) * 2004-01-30 2007-06-19 Asahi Kasei Chemicals Corp agregado de celulose porosa, processo para produzir o mesmo, e composição de produto moldado
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
NO20065147L (no) * 2006-11-08 2008-05-09 Ntnu Tech Transfer As Nanokompositter basert på cellulosewhiskers og celluloseplast
FR2945945B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Procede de preparation de particules creuses et leurs applications
CA2823168A1 (en) 2011-10-13 2013-04-18 Tokushu Tokai Paper Co., Ltd. Porous membrane and process for preparing the same
RU2542267C1 (ru) * 2011-10-13 2015-02-20 Токусю Токай Пейпер Ко., Лтд. Пористая мембрана и способ ее получения
RU2535205C1 (ru) * 2011-10-13 2014-12-10 Токусю Токай Пейпер Ко., Лтд. Сепаратор для электрохимического устройства и способ его получения
MX2013008027A (es) * 2011-10-13 2014-12-08 Tokushu Tokai Paper Co Ltd Membrana porosa y procedimiento para preparacion de la misma.
CN111116761B (zh) * 2019-11-13 2022-02-18 王卫 改性微晶纤维素的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286829A (no) * 1961-12-29
CS172640B1 (no) * 1974-05-30 1977-01-28
US4063017A (en) * 1976-04-22 1977-12-13 Purdue Research Foundation Porous cellulose beads and the immobilization of enzymes therewith
SE434848B (sv) * 1976-04-22 1984-08-20 Purdue Research Foundation Forfaringssett for framstellning av porosa cellulosaperlor
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4269859A (en) * 1979-04-19 1981-05-26 Brown Company Cellulose floc granules and process
GB8618811D0 (en) * 1986-08-01 1986-09-10 Approved Prescription Services Sustained release ibuprofen formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
JPS6443530A (en) * 1987-08-10 1989-02-15 Asahi Chemical Ind Porous cellulose particle and its production
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
US4806360A (en) * 1987-10-23 1989-02-21 Advanced Polymer Systems Synthetic melanin aggregates

Also Published As

Publication number Publication date
AU644887B2 (en) 1993-12-23
FI925531L (fi) 1992-12-04
EP0532611A1 (en) 1993-03-24
US5607695A (en) 1997-03-04
NO304726B1 (no) 1999-02-08
FI101195B1 (fi) 1998-05-15
WO1991018590A1 (en) 1991-12-12
DK0532611T3 (da) 1996-08-05
AU7994091A (en) 1991-12-31
EP0532611B1 (en) 1996-04-03
GR3020047T3 (en) 1996-08-31
CA2084680A1 (en) 1991-12-07
FI101195B (fi) 1998-05-15
ATE136213T1 (de) 1996-04-15
ES2086542T3 (es) 1996-07-01
SE9002017D0 (sv) 1990-06-06
DE69118533T2 (de) 1996-09-12
CA2084680C (en) 2001-10-02
FI925531A0 (fi) 1992-12-04
NO924671D0 (no) 1992-12-03
JPH05507696A (ja) 1993-11-04
DE69118533D1 (de) 1996-05-09

Similar Documents

Publication Publication Date Title
NO924671D0 (no) Fremgangsmaate for fremstilling av poroese cellulosematriser
ES8300137A1 (es) Un procedimiento para la preparacion de almidones tratados
MY103076A (en) Ibuprofen sustained release matrix and process
ES2023673B3 (es) Composicion de fibra comprimida en tabletas de alta densidad y digestible
ES8303090A1 (es) Procedimiento para la obtencion de comprimidos medicionales de rapida disgregacion.
MY104010A (en) Pharmaceutical compositions.
FI864207L (fi) Kontrollerad frigivning av kaliumklorid.
FI865227A0 (fi) Foerfarande foer framstaellning av ett depot-preparat.
JPS5759803A (en) Granule of l-sodium ascorbate, its preparation, and tablet comprising it
RU98104417A (ru) Комбинированные осмотические и объем-образующие слабительные средства
DE60212464D1 (de) Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit
FI954883A0 (fi) Matriisien valmistus
GR3003872T3 (no)
CA2277722A1 (en) Water dispersible tablets
US5215752A (en) Pharmaceutical tablets and capsule granulates of scleroglucan and active substance
FI910626A0 (fi) Menetelmä peroksoboraattiagglomeraattien valmistamiseksi